000 01142 a2200325 4500
005 20250516224418.0
264 0 _c20140728
008 201407s 0 0 eng d
022 _a2213-0489
024 7 _a10.1016/j.lrr.2014.06.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGoldberg, Stuart L
245 0 0 _aAn exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes.
_h[electronic resource]
260 _bLeukemia research reports
_c2014
300 _a58-61 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aFenaux, Pierre
700 1 _aCraig, Michael D
700 1 _aGyan, Emmanuel
700 1 _aLister, John
700 1 _aKassis, Jeannine
700 1 _aPigneux, Arnaud
700 1 _aSchiller, Gary J
700 1 _aJung, JungAh
700 1 _aJane Leonard, E
700 1 _aFingert, Howard
700 1 _aWestervelt, Peter
773 0 _tLeukemia research reports
_gvol. 3
_gno. 2
_gp. 58-61
856 4 0 _uhttps://doi.org/10.1016/j.lrr.2014.06.003
_zAvailable from publisher's website
999 _c24047493
_d24047493